Oncolytics Biotech Inc (ONCY)

Jun 18, 2025

Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going - PR Newswire

Jun 18, 2025

Jun 13, 2025

Oncolytics names Jared Kelly as CEO - MSN

Jun 13, 2025

Jun 12, 2025

Oncolytics Biotech stock takes off after naming new CEO - MSN

Jun 12, 2025

Jun 12, 2025

Big Cuts to U.S. Cancer Research May Create Historic Opening for Biotech Investors - Baystreet.ca

Jun 12, 2025

Jun 12, 2025

As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry - PR Newswire

Jun 12, 2025

Jun 12, 2025

After Major Oncology Conference, All Eyes Turn to Industry Innovation - PR Newswire

Jun 12, 2025

Jun 11, 2025

Oncolytics (ONCY) Names Jared Kelly as New CEO and Board Member - GuruFocus

Jun 11, 2025

Jun 11, 2025

Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immu - GuruFocus

Jun 11, 2025

Jun 11, 2025

Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences - GlobeNewswire

Jun 11, 2025

Jun 11, 2025

Oncolytics Biotech stock takes off after naming new CEO | 2025-06-11 | Investing News - Stockhouse

Jun 11, 2025

Jun 11, 2025

Oncolytics Biotech Inc. - Baystreet.ca

Jun 11, 2025

Jun 11, 2025

Stocks In Play: Oncolytics Biotech Inc. - Barchart.com

Jun 11, 2025

Jun 11, 2025

Stocks In Play: Oncolytics Biotech Inc By Baystreet.ca - Investing.com Canada

Jun 11, 2025

Jun 11, 2025

Oncolytics Biotech (ONCY) Appoints New CEO, Jared Kelly - GuruFocus

Jun 11, 2025

Jun 11, 2025

Oncolytics Biotech Inc - Baystreet.ca

Jun 11, 2025

Jun 11, 2025

Stocks In Play: Oncolytics Biotech Inc - Barchart.com

Jun 11, 2025

Jun 11, 2025

Oncolytics Biotech Appoints New CEO to Drive Immunotherapy Advancements - TipRanks

Jun 11, 2025

Jun 11, 2025

Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs | ONCY Stock News - GuruFocus

Jun 11, 2025

Jun 11, 2025

Oncolytics Biotech Taps $2B J&J Deal Architect as CEO, Accelerating Fast Track Cancer Programs - Stock Titan

Jun 11, 2025

Jun 10, 2025

(ONC) Investment Performance Report (ONC:CA) - news.stocktradersdaily.com

Jun 10, 2025

Jun 07, 2025

(ONC) Long Term Investment Analysis (ONC:CA) - news.stocktradersdaily.com

Jun 07, 2025

Jun 07, 2025

Oncolytics Biotech(R) to Present at the H.C. Wainwright 21st Annual Global Investment Conference - ACCESS Newswire

Jun 07, 2025

Jun 04, 2025

(ONC) Technical Patterns and Signals (ONC:CA) - news.stocktradersdaily.com

Jun 04, 2025

Jun 04, 2025

Exelixis Stock Surges 28% YTD: Should You Buy Now or Sell? - The Globe and Mail

Jun 04, 2025

Jun 02, 2025

(ONC) Market Dynamics and Trading Signals (ONC:CA) - news.stocktradersdaily.com

Jun 02, 2025

May 30, 2025

(ONC) Proactive Strategies (ONC:CA) - news.stocktradersdaily.com

May 30, 2025

May 29, 2025

Against the rise of early onset cancer: a Mugglehead roundup - Mugglehead Magazine

May 29, 2025

May 27, 2025

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga

May 27, 2025

May 25, 2025

(ONC) Advanced Equity Analysis (ONC:CA) - news.stocktradersdaily.com

May 25, 2025

May 24, 2025

HC Wainwright Has Pessimistic Outlook of TSE:ONC Q2 Earnings - Defense World

May 24, 2025

May 24, 2025

Stocks In Play - Baystreet.ca

May 24, 2025

May 24, 2025

Q2 EPS Forecast for Oncolytics Biotech Reduced by Analyst - Defense World

May 24, 2025

May 23, 2025

Stocks in play: Oncolytics Biotech® Inc. - The Globe and Mail

May 23, 2025

May 23, 2025

Investor Attention Turns to Biotech as Traditional Cancer Research Models Strain - Baystreet.ca

May 23, 2025

May 23, 2025

Dow slumps 460 points, or 1.1%, in early trading following Trump's latest tariff threats targeting Europe and Apple - The Globe and Mail

May 23, 2025

May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - marketscreener.com

May 23, 2025

May 23, 2025

Oncolytics Biotech Inc. to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities - marketscreener.com

May 23, 2025

May 23, 2025

Oncolytics (ONCY) Unveils Promising Phase I/II Clinical Trial Da - GuruFocus

May 23, 2025

May 23, 2025

Oncolytics Biotech Unveils Promising Pelareorep Data at ASCO 2025 - TipRanks

May 23, 2025

May 23, 2025

Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities | ONCY Stock News - GuruFocus

May 23, 2025

May 23, 2025

Oncolytics Brief: Presenting New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities - marketscreener.com

May 23, 2025

May 23, 2025

Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities - PR Newswire

May 23, 2025

May 23, 2025

HC Wainwright Issues Negative Outlook for TSE:ONC Earnings - Defense World

May 23, 2025

May 23, 2025

Oncolytics Biotech (NASDAQ:ONCY) Earns “Buy” Rating from HC Wainwright - Defense World

May 23, 2025

May 22, 2025

(ONC) Strategic Market Analysis (ONC:CA) - news.stocktradersdaily.com

May 22, 2025

May 21, 2025

ONCY: Analyst Reiterates Buy Rating with $5.00 Price Target | ONCY Stock News - GuruFocus

May 21, 2025

May 19, 2025

Analysts Set Oncolytics Biotech Inc. (NASDAQ:ONCY) Price Target at $4.33 - Defense World

May 19, 2025

May 18, 2025

Oncolytic Virus Therapy Market Detailed In New Research Report - openPR.com

May 18, 2025

May 18, 2025

Jones Trading Reaffirms “Hold” Rating for Oncolytics Biotech (NASDAQ:ONCY) - Defense World

May 18, 2025

May 17, 2025

Options Volatility and Implied Earnings Moves Today, May 16, 2025 - The Globe and Mail

May 17, 2025

May 17, 2025

(ONC) Market Performance Analysis (ONC:CA) - news.stocktradersdaily.com

May 17, 2025

May 16, 2025

Oncolytics Biotech (ONCY) Downgraded by Jones Trading | ONCY Sto - GuruFocus

May 16, 2025

May 16, 2025

Oncolytics (ONCY) Downgraded Amid CEO Search and Capital Concerns | ONCY Stock News - GuruFocus

May 16, 2025

May 15, 2025

Oncolytics Biotech’s Earnings Call: Optimism Amid Challenges - TipRanks

May 15, 2025

May 15, 2025

Stocks in play: Oncolytics Biotech Inc - The Globe and Mail

May 15, 2025

May 15, 2025

Oncolytics Biotech Inc (ONCY) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

May 15, 2025

May 15, 2025

Oncolytics Biotech Inc (ONCY) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus

May 15, 2025

May 15, 2025

Oncolytics Biotech Reports Q1 Results and Clinical Progress - TipRanks

May 15, 2025